[Beyond the Scene] After banning it for so long... Mounjaro policy flip-flops
As soon as the government allowed people to bring into South Korea obesity drugs prescribed overseas, Japanese medical institutions began stepping up efforts to attract Korean patients. Japanese cosmetic clinics that sell Mounjaro are advertising on social media that they offer Korean-language interpretation and telemedicine, and will even deliver medication to patients' hotels during their stay. A four-week supply of 2.5 mg Mounjaro costs around 300,000 won in South Korea, but can reportedly be prescribed in Japan for 7,000 yen (about 60,000 won). Online accounts of people saying that the medication is cheaper there even after adding airfare and accommodation costs are spreading.
The Ministry of Food and Drug Safety had designated Mounjaro and Wegovy as "harmful medicines," and customs authorities had used this designation to prohibit individuals from bringing in medicines they had purchased and carried themselves. The rationale was that it is difficult to verify the manufacturing and distribution channels or storage conditions of medicines bought overseas, and that consumer protections such as recalls and compensation are difficult to provide if problems arise.
The authorities also stressed that the measure was necessary to protect public health and safety, warning that injectable medicines requiring refrigeration could deteriorate during transport and be misused. Critics said it was excessive to impose a blanket ban even on medicines properly prescribed overseas and purchased for personal use. But health authorities had maintained a "complete ban" in the name of safety.
In the meantime, the price gap between South Korea and Japan for Mounjaro widened, and patients' dissatisfaction grew. In Japan, the government controls the price of Mounjaro covered by public health insurance, which has also brought down the price for private, out-of-pocket treatment. In South Korea, by contrast, negotiations have stalled over extending health insurance coverage even to patients with diabetes, leaving the authorities with no way to control the price of Mounjaro, which is effectively prescribed on a non-covered basis.
On Nov. 9, when Lee Jun-seok, a lawmaker from the Reform Party, questioned at the National Assembly whether it was appropriate to block people from bringing in medicines that had been lawfully prescribed, the government changed a regulation it had maintained for more than a year overnight. It decided to allow people to carry in up to a three-month supply of medicines prescribed and purchased overseas for their own treatment. Conflicting explanations from the Ministry of Food and Drug Safety and the Korea Customs Service also caused confusion over whether someone who had brought in a three-month supply could bring in more medication again soon afterward. The ministry said repeat imports were not allowed in principle because they would not meet the purpose of personal treatment. The customs service, however, acknowledged that there was no separate rule restricting repeat imports or system for tracking the import history of individuals.
Policies can never be perfect, and they may be revised as new problems or risks emerge. But before changing a policy, the government should explain what went wrong and clearly set out the new standards. The stated goal of protecting public health cannot justify every regulation, nor should safety concerns be overlooked in the name of prioritizing public convenience. More important than the strictness of a regulation are reasonable standards and consistency. If the government first imposes a complete ban on safety grounds, then rushes to allow imports after the National Assembly raises concerns, the public is left confused and trust in policy is eroded.
Hot Picks Today
"Two Spend 500,000 Won in a Flash, Yet Wait Two Hours?" ... 'Dreamland' Shunned by Kids and Foreign Tourists
- The Era of Getting 200 Million Won After 30 Years Is Over... A Japanese Bank's "Perpetual Department Head" Who Just Clocked In Cries Out
- Spain Hit by Its Worst Tragedy... Lee Kangin, Moreno and Real Madrid Join Soccer World in Mourning
- They Said, “Make It Your Home for Life” - Then Suddenly Kicked 200 Passengers Off... What Happened to the Around-the-World Cruise?
- "130 Rice Bowls Sold Out in a Day"... 'Unfiltered Face' Adds 8 Million Won to Night Market Sales: China's Bungeunwoo
It remains difficult to ensure that Mounjaro purchased overseas has been transported and stored properly. Because domestic medical professionals cannot check patients' medication histories, gaps may also arise in the management of adverse effects. Concerns are already being raised that proxy prescriptions and misuse could spread amid a boom in "medical tourism" for purchases. The government should now take a closer look at the standards for bringing medicines into the country and put practical measures in place to ensure safety throughout the drug distribution process. Above all, it must not ignore the price gap between South Korea and other countries that is encouraging overseas purchases, or the financial burden of medicines not covered by health insurance.
© The Asia Business Daily. All rights reserved. Unauthorized AI training and use prohibited.